These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28607730)

  • 1. Distractibility in multiple sclerosis: The role of depression.
    Patel VP; Zambrana A; Walker LA; Herrmann N; Swartz RH; Feinstein A
    Mult Scler J Exp Transl Clin; 2016; 2():2055217316653150. PubMed ID: 28607730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Processing speed and distractibility in multiple sclerosis: the role of sleep.
    Patel VP; Walker LA; Feinstein A
    Mult Scler Relat Disord; 2017 Jan; 11():40-42. PubMed ID: 28104254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distraction adds to the cognitive burden in multiple sclerosis.
    Patel VP; Zambrana A; Walker LA; Herrmann N; Feinstein A
    Mult Scler; 2017 Jan; 23(1):106-113. PubMed ID: 27012660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiety and depression affect performance on the symbol digit modalities test over time in MS and other immune disorders.
    Marrie RA; Patel R; Bernstein CN; Bolton JM; Graff LA; Marriott JJ; Hitchon CA; Figley CR; Kornelsen J; Fisk JD
    Mult Scler; 2021 Jul; 27(8):1284-1292. PubMed ID: 32976067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deconstructing the symbol digit modalities test in multiple sclerosis: The role of memory.
    Patel VP; Walker LAS; Feinstein A
    Mult Scler Relat Disord; 2017 Oct; 17():184-189. PubMed ID: 29055455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
    López-Góngora M; Querol L; Escartín A
    BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressive Symptoms Are Associated With More Negative Functional Outcomes Than Anxiety Symptoms in Persons With Multiple Sclerosis.
    Gill S; Santo J; Blair M; Morrow SA
    J Neuropsychiatry Clin Neurosci; 2019; 31(1):37-42. PubMed ID: 30187820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes and anxiety adversely affect cognition in multiple sclerosis.
    Marrie RA; Patel R; Figley CR; Kornelsen J; Bolton JM; Graff L; Mazerolle EL; Marriott JJ; Bernstein CN; Fisk JD;
    Mult Scler Relat Disord; 2019 Jan; 27():164-170. PubMed ID: 30384203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between depression, anxiety and cognition and its paradoxical impact on falls in multiple sclerosis patients.
    Kalron A; Aloni R; Allali G
    Mult Scler Relat Disord; 2018 Oct; 25():167-172. PubMed ID: 30086536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.
    Drake AS; Weinstock-Guttman B; Morrow SA; Hojnacki D; Munschauer FE; Benedict RH
    Mult Scler; 2010 Feb; 16(2):228-37. PubMed ID: 20028710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS).
    Charvet LE; Beekman R; Amadiume N; Belman AL; Krupp LB
    J Neurol Sci; 2014 Jun; 341(1-2):79-84. PubMed ID: 24792098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The link between depression and performance on the Symbol Digit Modalities Test: Mechanisms and clinical significance.
    Patel VP; Feinstein A
    Mult Scler; 2019 Jan; 25(1):118-121. PubMed ID: 29648500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
    Van Schependom J; D'hooghe MB; Cleynhens K; D'hooge M; Haelewyck MC; De Keyser J; Nagels G
    Eur J Neurol; 2014 Sep; 21(9):1219-25, e71-2. PubMed ID: 24850580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project.
    Walker LA; Osman L; Berard JA; Rees LM; Freedman MS; MacLean H; Cousineau D
    J Neurol Sci; 2016 Mar; 362():147-52. PubMed ID: 26944137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Norwegian translation of the brief international cognitive assessment for multiple sclerosis (BICAMS).
    Skorve E; Lundervold AJ; Torkildsen Ø; Myhr KM
    Mult Scler Relat Disord; 2019 Nov; 36():101408. PubMed ID: 31610403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression-Based Norms for the Symbol Digit Modalities Test in the Dutch Population: Improving Detection of Cognitive Impairment in Multiple Sclerosis?
    Burggraaff J; Knol DL; Uitdehaag BMJ
    Eur Neurol; 2017; 77(5-6):246-252. PubMed ID: 28319952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Two Versions of the Hospital Anxiety and Depression Scale in Assessing Depression in a Neurologic Setting.
    Patel VP; Feinstein A
    Cogn Behav Neurol; 2017 Dec; 30(4):145-149. PubMed ID: 29256909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binocular low-contrast letter acuity and the symbol digit modalities test improve the ability of the Multiple Sclerosis Functional Composite to predict disease in pediatric multiple sclerosis.
    Waldman AT; Chahin S; Lavery AM; Liu G; Banwell BL; Liu GT; Balcer LJ
    Mult Scler Relat Disord; 2016 Nov; 10():73-78. PubMed ID: 27919503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Videogame-Based Digital Therapeutic to Improve Processing Speed in People with Multiple Sclerosis: A Feasibility Study.
    Bove RM; Rush G; Zhao C; Rowles W; Garcha P; Morrissey J; Schembri A; Alailima T; Langdon D; Possin K; Gazzaley A; Feinstein A; Anguera J
    Neurol Ther; 2019 Jun; 8(1):135-145. PubMed ID: 30506301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.